TORONTO, ONTARIO--(Marketwire - March 24, 2010) - BioExx Specialty Proteins Ltd. (TSX: BXI) will release its 2009 annual financial results following the close of markets on Tuesday, March 30, 2009. Management will host a conference call on Wednesday, March 31 at 10:00 a.m. (Eastern Time) to review the financial results.
Live Conference Call: ---------------------- Dial-in Numbers: 416-340-8061 / 866-225-0198 Instant Replay: ---------------------- Dial-in Numbers: 416-695-5800 / 800-408-3053 Pass code: 3731147 Available Until: April 14, 2010 11:59 PM The call will also be audio-cast live and archived for 90 days at www.bioexx.com.
About BioExx Specialty Proteins Ltd.
Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.
To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com.
The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management’s current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx’s products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx’s plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’s expectations and projections.
Contacts:
BioExx Specialty Proteins Ltd.:
Chris Schnarr
Chief Financial Officer
(416) 588-4442 x111
cschnarr@bioexx.com
Investor Relations: Brisco Capital Partners
Scott Koyich
President
(403) 262-9888
scott@briscocapital.com
www.bioexx.com